104 results
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
venture, a corporation, a trust, an unincorporated organization, any other entity or a government or any department or agency thereof.
(mm) “Principal
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
23 May 24
Material Modifications to Rights of Security Holders
4:05pm
company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or a government or any department
8-K
EX-3.2
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
department or agency thereof.
(yy) “Price Failure” means, with respect to a particular date of determination, the VWAP of the Common Stock on any Trading
8-K
EX-3.1
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
, a joint venture, a corporation, a trust, an unincorporated organization, any other entity or a government or any department or agency thereof.
(mm
8-K
EX-10.4
TNFA
TNF Pharmaceuticals Inc.
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization or a government or any department or agency thereof
8-K
EX-4.1
i4sb z6u4ldh
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.2
1beysc 3agoyb
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.3
jqphzmihbqtsjrkaq
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.2
tgoju6
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.4
q874fs083pfcb3za
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-10.1
w5r1j3xq
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-4.3
s4rsmb5 m8
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
8-K
EX-3.1
17c34ee0u qh5ckvt
8 Apr 24
Entry into a Material Definitive Agreement
4:49pm
8-K
EX-3.1
so89glo
7 Mar 24
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-99.1
t43ko73d5mhydp
5 Mar 24
Regulation FD Disclosure
11:00am
8-K
EX-99.1
4hhcfy6rt vpg500g2
19 Oct 23
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced
9:00am
8-K
wnnnfzo8ddzbru
13 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm